Marcos Alessandro Santos Ribeiro

Marcos Alessandro Santos Ribeiro

Auto-generated profile, based on publicly available information

Marcos Alessandro Santos Ribeiro

Universidade Estadual de Maringá, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Natural Product Research
Verified
Journal Article
Closed access
APAndressa Domingos Polli
Andressa Domingos Polli
MRMarcos Alessandro dos Santos Ribeiro
Marcos Alessandro dos Santos Ribeiro
AGAdriana Garcia
Adriana Garcia
JPJulio Cesar Polonio
Julio Cesar Polonio
CSCaroline Menicoze Santos
Caroline Menicoze Santos
JAJoão Lúcio Azevedo
João Lúcio Azevedo
In the present study, the biological activity of an extract of the secondary metabolites (E-G6-32) produced by the Curvularia sp. G6-32 endophyte (isolated from the medicinal plant Sapindus saponaria L.) was investigated. The antioxidant potential was confirmed by the DPPH (22.5%) and ABTS (62.7%) assays, and the total phenolic compound content was 40 µg gallic acid equivalents/mg. The extract E-G6-32 displayed good inhibitory activity toward butyrylcholinesterase (BuChE; IC50 = 110 ± 0.05 µg mL−1). The extract E-G6-32 was subjected to spectroscopic and mass spectrometry analyses. Comparison with the literature data confirmed that (-)-asperpentyn (1) was a major component. Asperpentyn belongs to the epoxyquinone family, which has attractive structural complexity, diverse functional groups, and a broad range of biological activities, including specific enzyme inhibitory activity. Our results suggest that Curvularia sp. G6-32 is a promising source of bioactive secondary metabolites and contains (-)-asperpentyn, which has potential pharmaceutical interest.

23 November 2021 in Food Technology and Biotechnology
Verified
Journal Article
Open access
CSCristiana F. G. Silva
Cristiana F. G. Silva
VFVictor Fattori
Victor Fattori
CTCaroline R. Tonetti
Caroline R. Tonetti
MRMarcos A. S. Ribeiro
Marcos A. S. Ribeiro
RMRicardo Luís Nascimento de Matos
Ricardo Luís Nascimento de Matos
NANilton S. Arakawa
Nilton S. Arakawa
Research background. Extracts from grape pomace, including the wine, show many biological effects such as antioxidant and anti-inflammatory activities. Unfortunately, winemakers discard the bagasse, so the waste is not exploited, although it contains bioactive compounds with antioxidant and anti-inflammatory properties. The work aims to analyze the hydroethanolic extract of peels from Vitis labrusca agro-industrial waste and to evaluate its antinociceptive and anti-inflammatory properties. This study is relevant for reusing a residue and adding value to the grape economic chain. Experimental approach. A representative sample of pomace was obtained and the peels were used to produce the extract. The phenolic compounds were determined by mass spectrometry in multiple reaction monitoring mode and Folin-Ciocalteu colorimetric method, using gallic acid as standard. The biological analyses were carried out using mice orally treated with crude extract at doses of 30, 100 and 300 mg/kg. We evaluated mechanical hyperalgesia by the von Frey method, thermal heat hyperalgesia using a hot plate at 55 °C, paw edema using a Vernier caliper, and neutrophil recruitment by measurement of myeloperoxidase activity. The nephrotoxicity and hepatotoxicity were evaluated by biochemical analyses using blood samples that were collected after the Vitis labrusca administration. Results and conclusions. In all wet winemaking residues peel mass fraction was 75 %, and in dry residues 59 %. We identified nine anthocyanins (3-O-glucosides: peonidin, delphinidin, petunidin and malvidin; 3-p-coumaroyl-glucosides: cyanidin, peonidin, petunidin and malvidin, and malvidin-3,5-diglucoside), five flavonoids (apigenin-7-glucoside, luteolin-7-glucoside, quercetin-3-galactoside, isorhamnetin-3-glucoside and myricetin-3-rutinoside), and mass fraction of phenolic compounds, expressed as gallic acid equivalents, was 26.62 mg/g. In vivo assays showed that Vitis labrusca extract at mass fractions 100 and 300 mg/kg reduced carrageenan-induced mechanical and thermal hyperalgesia, 50 % of the paw edema, and neutrophil recruitment. In addition, there were no indications of nephrotoxicity and hepatotoxicity. Our extract obtained from winemaking residue has analgesic and anti-inflammatory properties, related at least in part to the presence of phenolic compounds, and it is not toxic to renal and hepatic tissues. Novelty and scientific contribution. This bio-product can be used as an alternative to synthetic anti-inflammatory agents with the same pharmacological potential and fewer side effects. We demonstrated that Vitis labrusca winemaking waste can be used for the production of antinociceptive and anti-inflammatory products (nutraceutical, pharmaceutical and cosmetics) without toxicity, contributing to the environmental economy.

1 August 2018 in International Journal of Mass Spectrometry
Verified
Journal Article
Closed access
ATAngélica P.P. Tonin
Angélica P.P. Tonin
CPCamila B. Poliseli
Camila B. Poliseli
MRMarcos A.S. Ribeiro
Marcos A.S. Ribeiro
LMLuiz Alberto Beraldo Moraes
Luiz Alberto Beraldo Moraes
JVJesuí V. Visentainer
Jesuí V. Visentainer
EMEduardo Cesar MEURER
Eduardo Cesar MEURER

1 January 2026 in Bragantia
Verified
Journal Article
Open access
FRFernanda Amaral Della Rosa
Fernanda Amaral Della Rosa
DRDaiane Medeiros Rappe
Daiane Medeiros Rappe
ATAngelica Parussolo Tonin
Angelica Parussolo Tonin
MRMarcos Alessandro Santos Ribeiro
Marcos Alessandro Santos Ribeiro
FSFelipe Sartori
Felipe Sartori
OFOsvaldo Guedes Filho
Osvaldo Guedes Filho
This study establishes LC-NL(46)-MS/MS as a selective and efficient method for profiling bioactive dipeptides in protein hydrolysates, addressing limitations of conventional full-scan analyses. Four formulations were evaluated: two commercial biostimulants (Biost1 and Biost2) and two prototypes (MVP1 and MVP2). Computational predictions revealed non-toxic dipeptides with diverse bioactivities, including ACE and DPP-IV inhibition, antioxidant effects, and similarities to CLE peptide fragments involved in plant signaling. MVP1 exhibited superior peptide diversity and CLE-related sequences, suggesting enhanced biostimulant potential. Field trials in soybean demonstrated the safety of these hydrolysates, with no negative impacts on growth or yield, though statistical significance was not achieved. Qualitative productivity gains (up to 8.7%) in MVP1 highlight their role as sustainable signaling mediators. These findings provide a foundation for quality control in biostimulant production and future research on combined formulations under stress conditions, emphasizing the dual function of protein hydrolysates as nutrient carriers and sources of bioactive peptides for agricultural applications.